{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:12:27Z","timestamp":1785773547805,"version":"3.56.0"},"reference-count":138,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T00:00:00Z","timestamp":1676160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is the second most common inflammatory neurodegenerative disorder after dementia. Preclinical and epidemiological data strongly suggest that chronic neuroinflammation slowly induces neuronal dysfunction. Activated microglia secrete several neurotoxic substances, such as chemokines and proinflammatory cytokines, which may promote blood\u2013brain barrier (BBB) permeabilization. CD4+ T cells comprise proinflammatory cells such as T helper (Th) 1 and Th17 cells, as well as anti-inflammatory cells such as Th2 and T regulatory cells (Tregs). Th1 and Th17 cells can be detrimental to dopamine neurons, whereas Th2 and Tregs are neuroprotective. The results of studies on the serum levels of cytokines such as IFN-\u03b3 and TNF-\u03b1 secreted by Th1 T cells, IL-8 and IL-10 secreted by Th2 T cells, and IL-17 secreted by Th17 cells in PD patients are not uniform. In addition, the relationships between serum cytokine levels and motor and non-motor symptoms of PD are controversial. Surgical stress and anesthesia induce inflammatory responses by disturbing the balance between pro- and anti-inflammatory cytokines, which may exacerbate the neuroinflammatory response in PD patients. Here we review studies on blood inflammatory biomarkers in PD patients and discuss the roles of surgery and anesthesia in PD progression.<\/jats:p>","DOI":"10.3390\/diagnostics13040693","type":"journal-article","created":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T05:25:26Z","timestamp":1676265926000},"page":"693","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Blood Biomarkers in Patients with Parkinson\u2019s Disease: A Review in Context of Anesthetic Care"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-9397","authenticated-orcid":false,"given":"Jin","family":"Joo","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongmin","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-1794","authenticated-orcid":false,"given":"Hue Jung","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,2,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson\u2019s disease: Advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.parkreldis.2011.02.018","article-title":"Parkinson\u2019s disease: The non-motor issues","volume":"17","author":"Chaudhuri","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fneur.2018.00213","article-title":"The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson\u2019s Disease","volume":"9","author":"Corrado","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"952375","DOI":"10.1155\/2013\/952375","article-title":"Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson\u2019s disease","volume":"2013","author":"More","year":"2013","journal-title":"Mediators Inflamm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.parkreldis.2004.01.005","article-title":"Inflammation and neurodegeneration in Parkinson\u2019s disease","volume":"10","author":"McGeer","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Elgueta","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a009381","DOI":"10.1101\/cshperspect.a009381","article-title":"Inflammation and adaptive immunity in Parkinson\u2019s disease","volume":"2","author":"Mosley","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","article-title":"Neuroinflammation in Parkinson\u2019s disease","volume":"4","author":"Lee","year":"2009","journal-title":"J. Neuroimmun. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3727\/096368908784423328","article-title":"Neuroinflammation and peripheral immune infiltration in Parkinson\u2019s disease: An autoimmune hypothesis","volume":"17","author":"Monahan","year":"2008","journal-title":"Cell Transpl."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.410240415","article-title":"Rate of cell death in parkinsonism indicates active neuropathological process","volume":"24","author":"McGeer","year":"1988","journal-title":"Ann. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cnr.2006.09.006","article-title":"Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson\u2019s Disease","volume":"6","author":"Mosley","year":"2006","journal-title":"Clin. Neurosci. Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Church, F.C. (2021). Treatment Options for Motor and Non-Motor Symptoms of Parkinson\u2019s Disease. Biomolecules, 11.","DOI":"10.3390\/biom11040612"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations (*)","volume":"28","author":"Zhu","year":"2010","journal-title":"Ann. Rev. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1178334","article-title":"Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells","volume":"327","author":"Paul","year":"2010","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11481-015-9618-9","article-title":"Regulation of the Neurodegenerative Process Associated to Parkinson\u2019s Disease by CD4+ T-cells","volume":"10","author":"Contreras","year":"2015","journal-title":"J. Neuroimmun. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pnpbp.2017.07.023","article-title":"The role of Th17 cells in auto-inflammatory neurological disorders","volume":"79 (Pt B)","author":"Tahmasebinia","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","article-title":"The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: A meta-analysis","volume":"38","author":"Jiang","year":"2017","journal-title":"Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"33738","DOI":"10.1038\/srep33738","article-title":"Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson\u2019s Disease","volume":"6","author":"Kustrimovic","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-na\u00efve and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflamm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/mds.26563","article-title":"Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD)","volume":"31","author":"Wijeyekoon","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00702-018-1857-5","article-title":"Interleukin 6 and complement serum level study in Parkinson\u2019s disease","volume":"125","author":"Dufek","year":"2018","journal-title":"J. Neural. Transm (Vienna)"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"704","DOI":"10.4103\/1673-5374.156958","article-title":"The innate immune system in Parkinson\u2019s disease: A novel target promoting endogenous neuroregeneration","volume":"10","author":"Schlachetzki","year":"2015","journal-title":"Neural Regen. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fneur.2019.00013","article-title":"Do Th17 Lymphocytes and IL-17 Contribute to Parkinson\u2019s Disease? A Systematic Review of Available Evidence","volume":"10","author":"Storelli","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lindqvist, D., Kaufman, E., Brundin, L., Hall, S., Surova, Y., and Hansson, O. (2012). Non-motor symptoms in patients with Parkinson\u2019s disease-correlations with inflammatory cytokines in serum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047387"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1080\/01616412.2015.1133026","article-title":"Levels of IL-8 and TNF-\u03b1 decrease in Parkinson\u2019s disease","volume":"38","author":"Gupta","year":"2016","journal-title":"Neurol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1470-2045(03)01282-8","article-title":"Excisional surgery for cancer cure: Therapy at a cost","volume":"4","author":"Coffey","year":"2003","journal-title":"Lancet Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.curtheres.2012.02.005","article-title":"Comparison of effects of low-flow sevoflurane and desflurane anesthesia on neutrophil and T-cell populations","volume":"73","author":"Ugur","year":"2012","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s11596-018-1970-6","article-title":"Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery","volume":"38","author":"Jiao","year":"2018","journal-title":"Curr. Med. Sci."},{"key":"ref_31","first-page":"7","article-title":"Desflurane versus sevoflurane: A comparison on stress response","volume":"79","author":"Marana","year":"2013","journal-title":"Minerva Anestesiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/00000539-200110000-00036","article-title":"Oxidative stress status during exposure to propofol, sevoflurane and desflurane","volume":"93","author":"Allaouchiche","year":"2001","journal-title":"Anesth. Analg."},{"key":"ref_33","first-page":"2062","article-title":"Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson\u2019s disease","volume":"11","author":"Shan","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.arth.2020.11.016","article-title":"Patients With Parkinson\u2019s Disease Have Poorer Function and More Flexion Contractures After Total Knee Arthroplasty","volume":"36","author":"Goh","year":"2021","journal-title":"J. Arthropl."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5152\/TJAR.2014.47135","article-title":"Parkinson\u2019s Disease and Spinal Anaesthesia","volume":"42","author":"Ergil","year":"2014","journal-title":"Turk. J. Anaesthesiol. Reanim."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1530\/EOR-22-0055","article-title":"The impact of Parkinson\u2019s disease on results of primary total knee arthroplasty","volume":"7","year":"2022","journal-title":"EFORT Open Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.arth.2017.11.017","article-title":"Total Joint Arthroplasty in Patients With Parkinson\u2019s Disease: Survivorship, Outcomes, and Reasons for Failure","volume":"33","author":"Rondon","year":"2018","journal-title":"J. Arthropl."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.parkreldis.2011.11.003","article-title":"Markers of inflammation in prevalent and incident Parkinson\u2019s disease in the Cardiovascular Health Study","volume":"18","author":"Ton","year":"2012","journal-title":"Parkinson. Relat. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13760-012-0015-3","article-title":"Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson\u2019s disease","volume":"112","author":"Andican","year":"2012","journal-title":"Acta Neurol. Belg."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sawada, H., Oeda, T., Umemura, A., Tomita, S., Hayashi, R., Kohsaka, M., Yamamoto, K., Sudoh, S., and Sugiyama, H. (2014). Subclinical elevation of plasma C-reactive protein and illusions\/hallucinations in subjects with Parkinson\u2019s disease: Case-control study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085886"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","article-title":"Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis","volume":"73","author":"Qin","year":"2016","journal-title":"JAMA Neurol."},{"key":"ref_42","first-page":"3853","article-title":"Relationship between levels of inflammatory cytokines in the peripheral blood and the severity of depression and anxiety in patients with Parkinson\u2019s disease","volume":"20","author":"Wang","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jocn.2018.10.079","article-title":"Peripheral blood inflammatory markers in early Parkinson\u2019s disease","volume":"58","author":"Kim","year":"2018","journal-title":"J. Clin. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/gps.5124","article-title":"Inflammation in mild cognitive impairment due to Parkinson\u2019s disease, Lewy body disease, and Alzheimer\u2019s disease","volume":"34","author":"King","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00702-019-02096-8","article-title":"High ultrasensitive serum C-reactive protein may be related to freezing of gait in Parkinson\u2019s disease patients","volume":"126","author":"Mir","year":"2019","journal-title":"J. Neural. Transm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10072-018-3611-z","article-title":"High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson\u2019s disease","volume":"40","author":"Baran","year":"2019","journal-title":"Neurol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"135259","DOI":"10.1016\/j.neulet.2020.135259","article-title":"Association of inflammatory factors and aging in Parkinson\u2019s disease","volume":"736","author":"Jin","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3233\/JPD-212914","article-title":"Peripheral Immune Cell Numbers and C-Reactive Protein in Parkinson\u2019s Disease: Results from a Population-Based Study","volume":"12","author":"Dommershuijsen","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","article-title":"Inflammatory cytokines and NT-proCNP in Parkinson\u2019s disease patients","volume":"60","author":"Koziorowski","year":"2012","journal-title":"Cytokine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.0000000000001308","article-title":"Parkinson disease with REM sleep behavior disorder: Features, \u03b1-synuclein, and inflammation","volume":"84","author":"Hu","year":"2015","journal-title":"Neurology"},{"key":"ref_51","first-page":"51","article-title":"Clinical parameters and the level of certain cytokines in blood and cerebrospinal fluid of patients with Parkinson\u2019s disease","volume":"93","author":"Milyukhina","year":"2015","journal-title":"Klin. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/ene.13223","article-title":"Inflammatory profile in LRRK2-associated prodromal and clinical PD","volume":"24","author":"Brockmann","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cellimm.2018.02.011","article-title":"Interleukin-1\u03b2, interleukin-1 receptor antagonist, interleukin-6, interleukin-10, and tumor necrosis factor-\u03b1 levels in CSF and serum in relation to the clinical diversity of Parkinson\u2019s disease","volume":"327","author":"Karpenko","year":"2018","journal-title":"Cell. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s12035-017-0404-y","article-title":"Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson\u2019s Disease","volume":"55","author":"Rocha","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2690205","DOI":"10.1155\/2019\/2690205","article-title":"Assessment of the Levels of Level of Biomarkers of Bone Matrix Glycoproteins and Inflammatory Cytokines from Saudi Parkinson Patients","volume":"2019","author":"Alrafiah","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3389\/fnins.2019.00255","article-title":"Tremor-Dominant in Parkinson Disease: The Relevance to Iron Metabolism and Inflammation","volume":"13","author":"Lian","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"577089","DOI":"10.1016\/j.jneuroim.2019.577089","article-title":"Inflammasome and \u03b1-synuclein in Parkinson\u2019s disease: A cross-sectional study","volume":"338","author":"Chatterjee","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","article-title":"Systemic activation of NLRP3 inflammasome and plasma \u03b1-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease","volume":"17","author":"Fan","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-5956-10-71","article-title":"An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes","volume":"10","author":"Mahlknecht","year":"2012","journal-title":"Proteome Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fneur.2018.01081","article-title":"Immune Cell Activation in the Cerebrospinal Fluid of Patients With Parkinson\u2019s Disease","volume":"9","author":"Pawlowski","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"208408","DOI":"10.1155\/2014\/208408","article-title":"Correlation between serum RANTES levels and the severity of Parkinson\u2019s disease","volume":"2014","author":"Tang","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/mds.27001","article-title":"Tau\/\u03b1-synuclein ratio and inflammatory proteins in Parkinson\u2019s disease: An exploratory study","volume":"32","author":"Gago","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.21307\/ane-2020-026","article-title":"Serum levels of hepcidin and interleukin 6 in Parkinson\u2019s disease","volume":"80","author":"Geremek","year":"2020","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10517-020-04723-x","article-title":"Plasma Cytokines Profile in Patients with Parkinson\u2019s Disease Associated with Mutations in GBA Gene","volume":"168","author":"Miliukhina","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s11357-020-00192-2","article-title":"A novel multi-marker discovery approach identifies new serum biomarkers for Parkinson\u2019s disease in older people: An EXosomes in PArkiNson Disease (EXPAND) ancillary study","volume":"42","author":"Calvani","year":"2020","journal-title":"Geroscience"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Rathnayake, D., Chang, T., and Udagama, P. (2019). Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: A case-control study. BMC Neurol., 19.","DOI":"10.1186\/s12883-019-1286-6"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jocn.2020.04.058","article-title":"Plasma cytokine profile in synucleinophaties with dementia","volume":"78","author":"Usenko","year":"2020","journal-title":"J. Clin. Neurosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-017-0935-1","article-title":"Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson\u2019s disease","volume":"14","author":"Eidson","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JPD-191724","article-title":"Senescence and Inflammatory Markers for Predicting Clinical Progression in Parkinson\u2019s Disease: The ICICLE-PD Study","volume":"10","author":"Yarnall","year":"2020","journal-title":"J. Parkinsons Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000460297","article-title":"Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease","volume":"23","author":"Suescun","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","article-title":"Increased serum levels of TNF-\u03b1 and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity","volume":"166","author":"Kouchaki","year":"2018","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the Peripheral Blood of Patients with Parkinson\u2019s Disease","volume":"25","author":"Bagheri","year":"2018","journal-title":"Neuroimmunomodulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2015.10.010","article-title":"Overnight S100B in Parkinson\u2019s Disease: A glimpse into sleep-related neuroinflammation","volume":"608","author":"Carvalho","year":"2015","journal-title":"Neurosci Lett."},{"key":"ref_75","first-page":"898192","article-title":"Interleukin-6 May Contribute to Mortality in Parkinson\u2019s Disease Patients: A 4-Year Prospective Study","volume":"2015","author":"Dufek","year":"2015","journal-title":"Parkinsons Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"689723","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and Fecal Markers of Intestinal Inflammation and Intestinal Barrier Permeability Are Elevated in Parkinson\u2019s Disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JPD-191699","article-title":"Plasma IL-6 and IL-17A Correlate with Severity of Motor and Non-Motor Symptoms in Parkinson\u2019s Disease","volume":"9","author":"Green","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11011-021-00801-9","article-title":"Serum fractalkine and 3-nitrotyrosine levels correlate with disease severity in Parkinson\u2019s disease: A pilot study","volume":"37","author":"Gupta","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/ane.12977","article-title":"Inflammation and fatigue in early, untreated Parkinson\u2019s Disease","volume":"138","author":"Herlofson","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"834580","DOI":"10.3389\/fneur.2022.834580","article-title":"CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers","volume":"13","author":"Lerche","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jns.2016.09.030","article-title":"IL-6 serum levels are elevated in Parkinson\u2019s disease patients with fatigue compared to patients without fatigue","volume":"370","author":"Pereira","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12974-019-1482-8","article-title":"Plasma VCAM1 levels correlate with disease severity in Parkinson\u2019s disease","volume":"16","author":"Perner","year":"2019","journal-title":"J. Neuroinflamm."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.25752","article-title":"Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson\u2019s disease","volume":"29","author":"Rocha","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.parkreldis.2021.09.019","article-title":"Soluble LAG-3 and Toll-interacting protein: Novel upstream neuro-inflammatory markers in Parkinson\u2019s disease","volume":"91","author":"Roy","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_85","first-page":"373","article-title":"Role of cytokines in inflammatory processes in Parkinson\u2019s disease","volume":"70","author":"Sawada","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3389\/fnins.2019.01057","article-title":"Peripheral humoral immune response is associated with the non-motor symptoms of Parkinson\u2019s disease","volume":"13","author":"Sun","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Umemura, A., Oeda, T., Yamamoto, K., Tomita, S., Kohsaka, M., Park, K., Sugiyama, H., and Sawada, H. (2015). Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136722"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-019-02043-7","article-title":"The contribution of cerebrovascular risk factors, metabolic and inflammatory changes to cognitive decline in Parkinson\u2019s disease: Preliminary observations","volume":"126","author":"Bohnen","year":"2019","journal-title":"J. Neural. Transm."},{"key":"ref_89","first-page":"17946","article-title":"The clinical significance of the imbalance of Th17 and Treg cells and their related cytokines in peripheral blood of Parkinson\u2019s disease patients","volume":"9","author":"Yang","year":"2016","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3389\/fneur.2018.01123","article-title":"Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson\u2019s Disease","volume":"9","author":"Yilmaz","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ejphar.2004.07.040","article-title":"Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity","volume":"500","author":"Dantzer","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(14)60687-5","article-title":"The systemic immune response to trauma: An overview of pathophysiology and treatment","volume":"384","author":"Lord","year":"2014","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"pe3","DOI":"10.1126\/scisignal.2003898","article-title":"Inflammatory cytokines at the summits of pathological signal cascades in brain diseases","volume":"6","author":"Steinman","year":"2013","journal-title":"Sci. Signal."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","article-title":"Glia and their cytokines in progression of neurodegeneration","volume":"26","author":"Mrak","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10357","article-title":"The ageing systemic milieu negatively regulates neurogenesis and cognitive function","volume":"477","author":"Villeda","year":"2011","journal-title":"Nature"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nm.3569","article-title":"Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice","volume":"20","author":"Villeda","year":"2014","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrn1824","article-title":"Astrocyte-endothelial interactions at the blood-brain barrier","volume":"7","author":"Abbott","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"Daneman","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"51817","DOI":"10.18632\/oncotarget.15545","article-title":"Critical role of matrix metallopeptidase 9 in postoperative cognitive dysfunction and age-dependent cognitive decline","volume":"8","author":"Bi","year":"2017","journal-title":"Oncotarget."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/cns.12018","article-title":"Surgery upregulates high mobility group box-1 and disrupts the blood-brain barrier causing cognitive dysfunction in aged rats","volume":"18","author":"He","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bja.2017.11.096","article-title":"Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice","volume":"120","author":"Hu","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"902","DOI":"10.3389\/fimmu.2017.00902","article-title":"Anesthesia and Surgery Impair Blood-Brain Barrier and Cognitive Function in Mice","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22664","article-title":"Resolving postoperative neuroinflammation and cognitive decline","volume":"70","author":"Terrando","year":"2011","journal-title":"Ann. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fncel.2016.00105","article-title":"Surgery-Induced Hippocampal Angiotensin II Elevation Causes Blood-Brain Barrier Disruption via MMP\/TIMP in Aged Rats","volume":"10","author":"Li","year":"2016","journal-title":"Front. Cell. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20518","DOI":"10.1073\/pnas.1014557107","article-title":"Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline","volume":"107","author":"Terrando","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2014.01.015","article-title":"Involvement of the blood-brain barrier opening in cognitive decline in aged rats following orthopedic surgery and high concentration of sevoflurane inhalation","volume":"1551","author":"Hu","year":"2014","journal-title":"Brain Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/nm.2514","article-title":"The neutrophil in vascular inflammation","volume":"17","author":"Phillipson","year":"2011","journal-title":"Nature Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevImmunol.2015015461","article-title":"Pathogenesis of multiple organ failure in sepsis","volume":"35","author":"Rossaint","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1971452","DOI":"10.1155\/2016\/1971452","article-title":"Oxidative stress after surgery on the immature heart","volume":"2016","author":"Fudulu","year":"2016","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/bja\/aei257","article-title":"Predictive perioperative factors for developing severe sepsis after major surgery","volume":"95","author":"Mokart","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s001340051320","article-title":"Immediate IL-10 expression following major orthopaedic trauma: Relationship to anti-inflammatory response and subsequent development of sepsis","volume":"26","author":"Giannoudis","year":"2000","journal-title":"Int. Care Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/bjs.1800790813","article-title":"Systemic cytokine response after major surgery","volume":"79","author":"Baigrie","year":"1992","journal-title":"Br. J. Surg."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0161-5890(02)00210-9","article-title":"The two faces of IL-6 on Th1\/Th2 differentiation","volume":"39","author":"Diehl","year":"2002","journal-title":"Mol. Immunol."},{"key":"ref_116","first-page":"287","article-title":"Effects of anesthetics and analgesics on natural killer cell activity","volume":"77","author":"Welden","year":"2009","journal-title":"AANA J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bpa.2004.01.002","article-title":"Effects of general anaesthesia on inflammation","volume":"18","author":"Schneemilch","year":"2004","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1213\/ANE.0000000000001403","article-title":"Mechanisms of the immunological effects of volatile anesthetics: A review","volume":"123","author":"Yuki","year":"2016","journal-title":"Anesth. Analg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1097\/00000542-200112000-00028","article-title":"Inhalation anesthetics induce apoptosis in normal peripheral lymphocytes in vitro","volume":"95","author":"Matsuoka","year":"2001","journal-title":"Anesthesiology"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Picq, C.A., Claren\u00e7on, D., Sinniger, V.E., Bonaz, B.L., and Mayol, J.F. (2013). Impact of anesthetics on immune functions in a rat model of vagus nerve stimulation. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067086"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jclinane.2004.12.017","article-title":"Effect of 2 anesthetic techniques on the postoperative proinflammatory and anti-inflammatory cytokine response and cellular immune function to minor surgery","volume":"17","author":"Schneemilch","year":"2005","journal-title":"J. Clin. Anesth."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/08923970701675085","article-title":"Enhancement of antitumor immunity after propofol treatment in mice","volume":"29","author":"Kushida","year":"2007","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2044.2010.06304.x","article-title":"Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients","volume":"65","author":"Ren","year":"2010","journal-title":"Anaesthesia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0192-0561(95)00026-X","article-title":"Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells","volume":"17","author":"Mitsuhata","year":"1995","journal-title":"Int. J. Immunopharmacol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/IJGM.S232770","article-title":"Spinal versus general anesthesia for patients with Parkinson\u2019s disease","volume":"13","author":"Aleshawi","year":"2020","journal-title":"Int. J. Gen. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.12659\/MSM.890981","article-title":"Influence of spinal and general anesthesia on the metabolic, hormonal, and hemodynamic response in elective surgical patients","volume":"20","author":"Milosavljevic","year":"2014","journal-title":"Med. Sci. Monit."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1213\/ANE.0b013e3182a1bf1c","article-title":"Neuraxial anesthesia decreases postoperative systemic infection risk compared with general anesthesia in knee arthroplasty","volume":"117","author":"Liu","year":"2013","journal-title":"Anesth. Analg."},{"key":"ref_128","first-page":"557","article-title":"Cerebrospinal fluid cytokine levels after surgery with spinal or general anesthesia","volume":"24","author":"Yeager","year":"1999","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bpa.2021.01.004","article-title":"Anesthetic care influences long-term outcomes: What is the evidence?","volume":"35","author":"Ramirez","year":"2021","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.21037\/atm-21-4392","article-title":"Can anesthetic effects and pain treatment influence the long-term prognosis of early-stage lymph node-negative breast cancer after breast-conserving surgery?","volume":"9","author":"Lu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2020.12.007","article-title":"Lung but not brain cancer cell malignancy inhibited by commonly used anesthetic propofol during surgery: Implication of reducing cancer recurrence risk","volume":"31","author":"Hu","year":"2021","journal-title":"J. Adv. Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3389\/fneur.2019.01245","article-title":"Diet in Parkinson\u2019s Disease: Critical Role for the Microbiome","volume":"10","author":"Jackson","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"104352","DOI":"10.1016\/j.nbd.2018.12.012","article-title":"Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease","volume":"135","author":"Dodiya","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1007\/s12035-016-0193-8","article-title":"Relationship Between Obesity, Alzheimer\u2019s Disease, and Parkinson\u2019s Disease: An Astrocentric View","volume":"54","author":"Echeverria","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4103\/1673-5374.320965","article-title":"Diabetes mellitus and Parkinson\u2019s disease: Dangerous liaisons between insulin and dopamine","volume":"17","author":"Montinaro","year":"2022","journal-title":"Neural. Regen. Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1002\/mds.26698","article-title":"Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson\u2019s disease","volume":"87","author":"Malek","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"261809","DOI":"10.1155\/2015\/261809","article-title":"Physical training regulates mitochondrial parameters and neuroinflammatory mechanisms in an experimental model of Parkinson\u2019s disease","volume":"2015","author":"Tuon","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Hwang, W.J., Joo, M.A., and Joo, J. (2020). Effects of anesthetic method on inflammatory response in patients with Parkinson\u2019s disease: A randomized controlled study. BMC Anesthesiol., 20.","DOI":"10.1186\/s12871-020-01112-9"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/693\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:32:32Z","timestamp":1760121152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/4\/693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,12]]},"references-count":138,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["diagnostics13040693"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13040693","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,12]]}}}